[{"AccountsPayableCurrent_0_Q2_USD":214100000.0,"DerivativeLiabilities_0_Q2_USD":1900000.0,"AmortizationOfFinancingCosts_2_Q2_USD":1800000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":472900000.0,"TreasuryStockValueAcquiredCostMethod_1_Q2_USD":0.0,"DebtCurrent_0_Q2_USD":300000.0,"PaymentsOfFinancingCosts_2_Q2_USD":6300000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":0.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":10300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":704200000.0,"CommonStockDividendsPerShareCashPaid_2_Q2_USD":0.1,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":25700000.0,"DerivativeAssetFairValueGrossLiability_0_Q2_USD":0.0,"DerivativeAssets_0_Q2_USD":22500000.0,"DerivativeCollateralObligationToReturnCash_0_Q2_USD":0.0,"DerivativeCollateralObligationToReturnSecurities_0_Q2_USD":1600000.0,"DerivativeCollateralRightToReclaimCash_0_Q2_USD":0.0,"GainLossOnSaleOfBusiness_2_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":19100000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":9900000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":2039600000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":1448400000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":5400000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":700900000.0,"EarningsPerShareDiluted_2_Q2_USD":-1.07,"EarningsPerShareDiluted_1_Q2_USD":-0.44,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-600000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":322300000.0,"InventoryValuationReserves_0_Q2_USD":102000000.0,"DerivativeCollateralRightToReclaimSecurities_0_Q2_USD":1600000.0,"TreasuryStockShares_0_Q2_shares":46100000.0,"AccountsNotesAndLoansReceivableNetCurrent_0_Q2_USD":500200000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-28300000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-280400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1109100000.0,"PaymentsOfDividends_2_Q2_USD":44000000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":38800000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":73600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-44800000.0,"TreasuryStockValue_0_Q2_USD":2416200000.0,"DerivativeFairValueOfDerivativeAsset_0_Q2_USD":22500000.0,"DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_0_Q2_USD":20900000.0,"DerivativeFairValueOfDerivativeLiability_0_Q2_USD":1900000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":138800000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":-7500000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":-2900000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q2_USD":-1500000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_Q2_USD":-3100000.0,"OtherNoncashIncomeExpense_2_Q2_USD":3700000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":2700000.0,"PaymentsForDerivativeInstrumentFinancingActivities_2_Q2_USD":30500000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":101000000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":0.0,"ProceedsFromRepaymentsOfShortTermDebt_2_Q2_USD":-1200000.0,"RestructuringAndRelatedCostIncurredCost_1_Q2_USD":1300000.0,"RestructuringAndRelatedCostIncurredCost_2_Q2_USD":43800000.0,"RestructuringCharges_1_Q2_USD":1300000.0,"RestructuringCharges_2_Q2_USD":43800000.0,"RestructuringCosts_2_Q2_USD":4500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":490600000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1364900000.0,"ProceedsFromDerivativeInstrumentInvestingActivities_2_Q2_USD":57500000.0,"InvestmentIncomeInterest_2_Q2_USD":1400000.0,"NumberOfReportingUnits_2_Q2_reportingUnit":5.0,"LineOfCreditFacilityRemainingBorrowingCapacity_0_Q2_USD":1156100000.0,"DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_0_Q2_USD":300000.0,"DerivativeLiabilityFairValueGrossAsset_0_Q2_USD":0.0,"DividendsCash_1_Q2_USD":21900000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-7800000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":1100000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":2100000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-12700000.0,"GoodwillGross_0_Q2_USD":6120400000.0,"NumberOfOperatingSegments_2_Q2_segment":2.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q2_USD":2893200000.0,"IncomeTaxReconciliationOtherReconcilingItems_1_Q2_USD":900000.0,"IncreaseDecreaseInAccountsAndNotesReceivable_2_Q2_USD":-268700000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-14600000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-5900000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-8600000.0,"InventoryRawMaterialsAndSuppliesNetOfReserves_0_Q2_USD":147800000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":78800000.0,"LIFOInventoryAmount_0_Q2_USD":7900000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2_Q2_USD":38700000.0,"InvestmentIncomeInterest_1_Q2_USD":1000000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-32400000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-249600000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":19400000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":164400000.0,"NetIncomeLoss_1_Q2_USD":-95400000.0,"NetIncomeLoss_2_Q2_USD":-235300000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":204700000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":700000.0,"ProfitLoss_2_Q2_USD":-235800000.0,"ProfitLoss_1_Q2_USD":-95900000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":528200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":771700000.0,"StockholdersEquity_0_Q2_USD":4643100000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":486900000.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":1100200000.0,"InterestExpense_1_Q2_USD":12300000.0,"InterestExpense_2_Q2_USD":19000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":1124700000.0,"OperatingIncomeLoss_1_Q2_USD":-104300000.0,"LiabilitiesCurrent_0_Q2_USD":763000000.0,"Liabilities_0_Q2_USD":3958800000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":61700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-644700000.0,"AdditionalPaidInCapital_0_Q2_USD":6576700000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4200000.0,"Assets_0_Q2_USD":8604200000.0,"AssetsCurrent_0_Q2_USD":2362900000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1109100000.0,"CommonStockSharesIssued_0_Q2_shares":264500000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":8604200000.0,"CommonStockSharesOutstanding_0_Q2_shares":218400000.0,"Depreciation_2_Q2_USD":64500000.0,"GrossProfit_1_Q2_USD":176100000.0,"GrossProfit_2_Q2_USD":643900000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-24000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-13800000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-88700000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-33000000.0,"InventoryNet_0_Q2_USD":548900000.0,"CommonStockValue_0_Q2_USD":2600000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":-6500000.0,"OperatingIncomeLoss_2_Q2_USD":-229100000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":1.0,"InventoryLIFOReserve_0_Q2_USD":15900000.0,"LongTermDebtNoncurrent_0_Q2_USD":2182700000.0,"MinorityInterest_0_Q2_USD":2300000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-500000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-500000.0,"OtherAssetsNoncurrent_0_Q2_USD":64000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":218700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":219800000.0,"Goodwill_0_Q2_USD":3227200000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-138600000.0,"GoodwillImpairmentLoss_2_Q2_USD":156600000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-28400000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-280800000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":100000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":400000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-44600000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":67600000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-119900000.0,"GoodwillImpairmentLoss_1_Q2_USD":0.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":140000000.0,"EarningsPerShareBasic_2_Q2_USD":-1.07,"CostOfGoodsAndServicesSold_2_Q2_USD":721000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":250000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":279100000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":672600000.0,"ShareBasedCompensation_2_Q2_USD":19700000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":218700000.0,"EarningsPerShareBasic_1_Q2_USD":-0.44,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":219800000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":439200000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1000000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":2530200000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":1430000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-4300000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-2900000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":4645400000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":314500000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":93800000.0,"TangibleAssetImpairmentCharges_2_Q2_USD":0.0,"Ticker":"XRAY","CIK":"818479","name":"DENTSPLY SIRONA INC.","OfficialName":"DENTSPLY SIRONA Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9092055663.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"SP500","filed":"20200806"}]